Noriyoshi Kanemura1, Rei Shibata2, Koji Ohashi3, Hayato Ogawa1, Mizuho Hiramatsu-Ito1, Takashi Enomoto1, Daisuke Yuasa1, Masanori Ito1, Satoko Hayakawa1, Naoya Otaka1, Toyoaki Murohara1, Noriyuki Ouchi4. 1. Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. 2. Department of Advanced Cardiovascular Therapeutics, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: rshibata@med.nagoya-u.ac.jp. 3. Molecular Cardiovascular Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan. 4. Molecular Cardiovascular Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: nouchi@med.nagoya-u.ac.jp.
Abstract
BACKGROUND AND AIMS: Obesity contributes to the progression of vascular disorders. C1q/TNF-related protein (CTRP) 1 is a circulating adipokine, which is upregulated in obese complications including coronary artery disease. Here, we investigated the role of CTRP1 in regulation of vascular remodeling after mechanical injury and evaluated its potential mechanism. METHODS: Mice were subjected to wire-induced injury of left femoral arteries. An adenoviral vector encoding CTRP1 (Ad-CTRP1) or β-galactosidase as a control was injected into the jugular vein of mice 3 days prior to surgery. RESULTS: Systemic administration of Ad-CTRP1 to wild-type mice led to reduction of the neointimal thickening after wire-induced arterial injury and the number of bromodeoxyuridine-positive cells in injured vessels as compared with treatment with control vectors. Treatment of vascular smooth muscle cells (VSMCs) with CTRP1 protein attenuated proliferative activity and ERK phosphorylation in response to PDGF-BB. CTRP1 treatment increased cyclic AMP (cAMP) levels in VSMCs, and inhibition of adenylyl cyclase reversed the inhibitory effect of CTRP1 on VSMC growth and ERK phosphorylation. Antagonization of sphingosine-1-phosphaterote (S1P) receptor 2 blocked the effects of CTRP1 on cAMP production and VSMC growth. Furthermore, CTRP1-knockout mice had enhanced neointimal thickening following injury and increased numbers of proliferating cells in neointima compared to control WT mice. CONCLUSIONS: These findings indicate that CTRP1 functions to prevent the development of pathological vascular remodeling by reducing VSMC growth through the cAMP-dependent pathway.
BACKGROUND AND AIMS: Obesity contributes to the progression of vascular disorders. C1q/TNF-related protein (CTRP) 1 is a circulating adipokine, which is upregulated in obese complications including coronary artery disease. Here, we investigated the role of CTRP1 in regulation of vascular remodeling after mechanical injury and evaluated its potential mechanism. METHODS:Mice were subjected to wire-induced injury of left femoral arteries. An adenoviral vector encoding CTRP1 (Ad-CTRP1) or β-galactosidase as a control was injected into the jugular vein of mice 3 days prior to surgery. RESULTS: Systemic administration of Ad-CTRP1 to wild-type mice led to reduction of the neointimal thickening after wire-induced arterial injury and the number of bromodeoxyuridine-positive cells in injured vessels as compared with treatment with control vectors. Treatment of vascular smooth muscle cells (VSMCs) with CTRP1 protein attenuated proliferative activity and ERK phosphorylation in response to PDGF-BB. CTRP1 treatment increased cyclic AMP (cAMP) levels in VSMCs, and inhibition of adenylyl cyclase reversed the inhibitory effect of CTRP1 on VSMC growth and ERK phosphorylation. Antagonization of sphingosine-1-phosphaterote (S1P) receptor 2 blocked the effects of CTRP1 on cAMP production and VSMC growth. Furthermore, CTRP1-knockout mice had enhanced neointimal thickening following injury and increased numbers of proliferating cells in neointima compared to control WT mice. CONCLUSIONS: These findings indicate that CTRP1 functions to prevent the development of pathological vascular remodeling by reducing VSMC growth through the cAMP-dependent pathway.
Authors: Michal Kasher Meron; Shuo Xu; Marshall J Glesby; Qibin Qi; David B Hanna; Kathryn Anastos; Robert C Kaplan; Jorge R Kizer Journal: AIDS Res Hum Retroviruses Date: 2019-09-03 Impact factor: 2.205
Authors: Susana Rodriguez; Hannah C Little; Parnaz Daneshpajouhnejad; Paride Fenaroli; Stefanie Y Tan; Dylan C Sarver; Michael Delannoy; C Conover Talbot; Sandeep Jandu; Dan E Berkowitz; Jennifer L Pluznick; Avi Z Rosenberg; G William Wong Journal: Am J Physiol Regul Integr Comp Physiol Date: 2020-10-21 Impact factor: 3.619
Authors: Dong Kyu Lee; Young Sil Min; Seong Su Yoo; Hyun Sub Shim; Sun Young Park; Uy Dong Sohn Journal: Biomol Ther (Seoul) Date: 2018-11-01 Impact factor: 4.634
Authors: Diego Barbieri; Marian Goicoechea; Maria Dolores Sánchez-Niño; Alberto Ortiz; Eduardo Verde; Ursula Verdalles; Ana Pérez de José; Andrés Delgado; Esther Hurtado; Luis Sánchez-Cámara; Nieves Lopez-Lazareno; Ana García-Prieto; José Luño Journal: Clin Kidney J Date: 2018-10-11
Authors: Susana Rodriguez; Hannah C Little; Parnaz Daneshpajouhnejad; Blythe D Shepard; Stefanie Y Tan; Andrew Wolfe; Muhammad Umar Cheema; Sandeep Jandu; Owen M Woodward; C Conover Talbot; Dan E Berkowitz; Avi Z Rosenberg; Jennifer L Pluznick; G William Wong Journal: FASEB J Date: 2019-12-26 Impact factor: 5.191